Viewing Study NCT03301467

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:28 AM
Ignite Modification Date: 2026-02-02 @ 8:20 AM
Study NCT ID: NCT03301467
Status: COMPLETED
Last Update Posted: 2025-03-13
First Post: 2017-09-22
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Controlled Trial Evaluating Avacopan in C3 Glomerulopathy
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None C3 Glomerulopathy (C3G) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None C3 Glomerulonephritis View
None C3 glomerulopathy View
None C3G View
None DDD View
None dense deposit disease View
None membranoproliferative glomerulonephritis View
None MPGN View
None C3GN View
None idiopathic MPGN View